According to GlobalData’s medical device pipeline database, 32 Artificial Disc Replacement Systems devices are in various stages of development globally. GlobalData’s report Artificial Disc Replacement Systems provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, nine are in active development, while the remaining 23 are in an inactive stage of development. There are five products in the early stages of development, and the remaining four are in the late stages of development.
Orthopedic devices are medical devices that are used to treat or prevent musculoskeletal disorders. Artificial Disc Replacement offers an alternative to spinal fusion for the patients who have chronic back pain from degenerative disc disease. It allows natural motion in the part of the spine where the disc is implanted and thus allows for an early return to function. The implant is designed so that it can withstand bending, compression and repeated loads during movement. Artificial Disc Replacement systems include Cervical Total Disc Replacement Systems and Lumbar Total Disc Replacement Systems. ADRSs are of two types of Ball-and-sockets ADRSs consist of two metal ball-and-socket joints that are held in place by a titanium or stainless steel cage. The ball-and-socket joints allow for more motion than other types of ADRSs, but they can also be more prone to wear and tear and cemented ADRSs consist of a metal or ceramic disc that is cemented into place between two vertebrae. Cemented ADRSs are less likely to wear and tear than ball-and-socket ADRSs, but they offer less motion.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Artificial Disc Replacement Systems pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Artificial Disc Replacement Systems devices. Overall, most of these Artificial Disc Replacement Systems pipeline devices are being developed by private entities.
Key players involved in the active development of Artificial Disc Replacement Systems include ZimVie, SpineSmith Holdings, TrueMotion Spine, Meliora Medical, SeaSpine, SINTX Technologies, Smart Disc, SpinalMotion, Spineart Geneva and MiMedx Group.
For a complete picture of the developmental pipeline for Artificial Disc Replacement Systems devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
